The Outcome of Using Long-Acting Insulin Glargine with Regular Insulin Infusion in Diabetic Ketoacidosis Patients with Renal Impairment: A Randomized Clinical Trial
| Author | Mona Ammar | en |
| Author | Eeman Aboubakr | en |
| Author | Wael Abdelmoneim | en |
| Issued Date | 2023-09-30 | en |
| Abstract | Background: Diabetic ketoacidosis (DKA) is considered one of the most severe as well as immediate diabetes mellitus complications. A continuous infusion of regular insulin is the most effective technique for treatment. A long-acting insulin analog, including insulin glargine, is used to initially treat DKA by supplying background insulin. The study investigated the impact of insulin glargine on kidney disease patients with altered insulin pharmacokinetics and pharmacodynamics. | en |
| DOI | https://doi.org/10.22037/jcma.v8i2.39294 | en |
| Keyword | Diabetic ketoacidosis | en |
| Keyword | Glargine, Insulin infusion | en |
| Keyword | Renal impairment | en |
| Keyword | Regular insulin | en |
| Publisher | Brieflands | en |
| Title | The Outcome of Using Long-Acting Insulin Glargine with Regular Insulin Infusion in Diabetic Ketoacidosis Patients with Renal Impairment: A Randomized Clinical Trial | en |
| Type | Research Article | en |
Files
Original bundle
1 - 1 of 1
Loading...
- Name:
- jcma-151430.pdf
- Size:
- 627.92 KB
- Format:
- Adobe Portable Document Format
- Description:
- Article/s PDF